EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China

Jing Wang, Weiwei Cai, Jiaxin Chen, Jing Chen, Wanli Yang

Frontiers in Public Health · 09.10.2026 · 14

DOI: 10.3389/fpubh.2026.1916685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 09.10.2026. Verfasst von Jing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease Control and Prevention, Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution)…. Hauptthemen laut MEDLINE: Rabies, Immunoglobulins, Rabies Vaccines. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rabies is an almost invariably fatal, vaccine-preventable zoonosis. Rabies immunoglobulin (RIG) is recommended for Category III exposures, yet real-world RIG utilization remains poorly characterized. This study examined temporal trends and factors associated with RIG utilization and delayed presentation among Category III exposure patients in China.

Methods

A retrospective study was conducted using clinical records of Category III exposure patients presenting to a high-volume rabies prevention clinic in Hangzhou, China, from 2015 to 2024. Calendar year 2018 was treated as a temporal reference year for descriptive comparison. Multivariable logistic regression identified factors associated with RIG non-administration and delayed presentation (>24 h post-exposure).

Results

A total of 14,270 eligible cases were analyzed. Overall RIG utilization was 37.54%, declining from 53.09% in 2015 to 7.14% in 2022. RIG non-administration was independently associated with male sex (OR 1.20, 95% CI 1.11–1.29), age 18–59 years (OR 3.25, 95% CI 2.95–3.59), exposure at home (OR 1.47, 95% CI 1.33–1.63), presentation in 2018 (OR 2.38, 95% CI 2.01–2.82) and in 2019–2024 (OR 4.49, 95% CI 3.96–5.09), and delayed presentation (OR 1.43, 95% CI 1.32–1.55). The overall delayed presentation rate was 34.47%; independent risk factors included age 18–59 years (OR 1.37, 95% CI 1.24–1.52), exposure at home (OR 1.57, 95% CI 1.41–1.74), and presentation in 2018 (OR 1.61, 95% CI 1.40–1.86) and in 2019–2024 (OR 1.77, 95% CI 1.62–1.94).

Conclusion

RIG utilization was low and showed marked temporal variation during 2015–2024, and one third of patients presented more than 24 h after exposure. Both outcomes were concentrated among working-age adults and domestic exposure settings. These findings describe service utilization patterns and identify subgroups in which gaps in PEP delivery are concentrated; targeted risk communication and routine monitoring of RIG utilization and presentation timeliness are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RabiesImmunoglobulinsRabies VaccinesHumansChinaRetrospective StudiesMaleFemaleAdultMiddle AgedAdolescentYoung AdultTreatment DelayChildChild, Preschool

Stichwörter der Autor:innen

delayed presentationpost-exposure prophylaxisrabiesrabies immunoglobulinreal-world study

Substanzen

ImmunoglobulinsRabies Vaccines

Autor:innen und Institutionen

  • Department of Infectious Disease Control and Prevention, Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution), Hangzhou, China.
  • Department of Epidemiology and Biostatistics, School of Public Health and The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of General Medicine, Hangzhou Occupational Disease Prevention and Treatment Hospital, Hangzhou, China.

Zitieren

APA

Wang, J., Cai, W., Chen, J., Chen, J., & Yang, W. (2026). Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1916685

Vancouver

Wang J, Cai W, Chen J, Chen J, Yang W. Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1916685

BibTeX
@article{Wang2026,
  author = {Wang, Jing and Cai, Weiwei and Chen, Jiaxin and Chen, Jing and Yang, Wanli},
  title = {Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1916685}
}
Kostenlos starten →